FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Baxter Recalls Novum IQ Syringe Pump

[ Price : $8.95]

Baxter recalls its Novum IQ large volume pump after becoming aware of the potential for underinfusion following use of the devices...

House Subcommittee Advances FDA Budget Bill

[ Price : $8.95]

A House Subcommittee markup votes along party lines to vote out and advance the agencys FY 2026 spending bill to the full committe...

FDA OKs Petition to Correct Phathom Patent Listing

[ Price : $8.95]

FDA approves a Phathom Pharmaceuticals citizen petition that corrects an agency Orange Book listing to recognize 10 years of new c...

Amneal Recalls Contaminated Tablets

[ Price : $8.95]

Amneal Pharmaceutical recalls three lots of sulfamethoxazole/trimethoprim tablets because they may exhibit black spots on their ta...

Arvinas Files NDA for Breast Cancer Drug

[ Price : $8.95]

Arvinas files an NDA for vepdegestrant for treating patients with estrogen receptor-positive human epidermal growth factor recepto...

FDA Platform Technology OK for Sarepta Vector

[ Price : $8.95]

FDA grants platform technology designation to a Sarepta viral vector used in an investigational gene therapy to treat a form of mu...

New Safety-Related Hernia Mesh Label Recommendations

[ Price : $8.95]

FDA posts a draft guidance entitled Hernia Mesh Package Labeling Recommendations.

Drug Labeling Improved for Pregnant Women: FDA

[ Price : $8.95]

FDA confirms that all drugs now have updated labeling to better provide health risk information to pregnant women.

4 States Want Mifepristone REMS Ended

[ Price : $8.95]

California, Massachusetts, New Jersey, and New York ask FDA to cancel the mifepristone REMS program requirements in their states o...

Makary Pushes for Reductions in Regulatory Barriers

[ Price : $8.95]

FDA commissioner Marty Makary promises that the agency will listen to stakeholder ideas on reducing regulatory barriers and evolvi...